Table 2.

Atherogenic and antiatherogenic elements in the plaques and blood of symptomatic and asymptomatic patients.

		Symptomatic (n = 6)	Asymptomatic (n = 13)	P value
Plaque	PON lactonase activity (U/mg proteins)	0.16 ± 0.035  (n = 8)	0.18 ± 0.054  (n = 9)	N.S.
	Triglyceride (% of LLE)	3.4 ± 1.07	2.37 ± 0.37	N.S.
	7-keto (% of cholesterol)	0.38 ± 0.19	0.25 ± 0.05	N.S.
	26-OH (% of cholesterol)	1.16 ± 0.27	1.29 ± 0.19	N.S.
	7α-OH (% of cholesterol)	0.087 ± 0.015	0.085 ± 0.01	N.S.
	7β-OH (% of cholesterol)	0.075 ± 0.01	0.08 ± 0.009	N.S.
	β-epoxy (% of cholesterol)	0.096 ± 0.01	0.114 ± 0.02	N.S.
	α-epoxy (% of cholesterol)	0.055 ± 0.004	0.069 ± 0.008	N.S.
	LA-13OOH (μg/mg plaque)	0.012 ± 0.002	0.0053 ± 0.0009	0.019
Serum	PON1 lactonase activity (U/mL)	38 ± 3.2	45 ± 2.9	N.S.
	HbA1c (%)	7.17 ± 0.48	6.04 ± 0.15	0.065
	HDL (mg/dL)	37.8 ± 3.35	51.7 ± 3.06	0.009
	LDL (mg/dL)	79 ± 13.2	90.9 ± 4.4	N.S.
	Cholesterol (mg/dL)	158.6 ± 11.2	168.08 ± 6.4	N.S.
	Triglyceride (mg/dL)	164.8 ± 27	127.2 ± 15.2	N.S.

LLE: lesion lipid extract. Results are presented as mean ± SEM.